Baxter International Inc. / ESI Lederle (Wyeth generic injectable business)
2002 · Acquisition/Merger · $316M · Complete
Announcement Sentiment
58
Neutral / mixed
Announced June 8, 2002. $305-316M cash and assumed liabilities. FTC cleared with divestitures of propofol, neuromuscular blockers. Acquired Cherry Hill NJ facility + 1000 employees. Tier 2 (FTC) verified.